Covid-19: US to begin treating seriously ill patients with Remdesivir drug

Gilead has accelerated its production of the antiviral and last week said that it was confident it would have "several million" doses available by the end of this year

The US is planning to begin treating some of the most seriously ill Covid-19 patients with with the antiviral medication Remdesivir, the maker of the drug has announced, as tensions continued across the country over the economic reopening of states.

The medication, recently given fast-track approval for use in the US, could be administered apart from clinical trials as early as Monday to the first coronavirus patients, while manufacturer Gilead is making plans to export it to other nations who give it the green light, news agency IANS reported.

"We are now firmly focused on getting this medicine to the